| Application no. and date | 14783642.3 (espacenet) (Federated) (European Patent Register), 20141013 | | Patent/reg. no. and date | DK/EP 3057580, 20210224 | | Publication date | 20160824 | | Priority no. and date | EP 13189145, 20131017 | | EP pub. no. and date |
EP 3057580 20160824 | | Effective date | | | Applicant/owner | Bayer Pharma Aktiengesellschaft, Müllerstrasse 178
13353 Berlin, DE | | Applicant ref. no. | 1578803 | | Inventor | BENKE, Klaus, Malteserweg 16
51465 Bergisch Gladbach, DE,
WINTER, Gabriele, am Kiesgrund 24a
16548 Glienicke, DE,
FORMELL, Michael, Am Kiesgrund 24a
16548 Glienicke, DE,
NEUMANN, Heike, Hindenburgstr. 143
42117 Wuppertal, DE | | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB, GB | | Opponent | | | IPC Class | A61K 31/5377 (2006.01) , A61K 9/20 (2006.01) , A61K 9/28 (2006.01) , A61P 13/12 (2006.01) , A61P 7/06 (2006.01) , A61P 9/04 (2006.01) | | Title | FARMACEUTISKE ADMINISTRATIONSFORMER INDEHOLDENDE NATRIUM-1-[6-(MORPHOLIN-4-YL)PYRIMIDIN-4-YL]-4-(1H-1,2,3-TRIAZOL-1-YL)-1H-PYRAZOL-5-OLAT | | Int. application no. | EP2014071855 | | Int. publication no. | WO2015055564 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
